Pharmaceutical News

Johnson & Johnson , Pfizer Inc. A ,A Amgen, Inc. A : The FDA released guidelines for the first shortcut to the U.S. market for "biosimilar" drugs, less expensive versions of expensive and complex medicines made from biological matter.

The Public Health committee plans to hear from doctors and patients, hospital and pharmaceutical industry representatives, and an official of the U.S. Food and Drug Administration during Monday's Statehouse hearing.

The healthcare industry has long been an option both for patients to get healthy and for investors to increase the worth of their portfolios.

Eggs that have hard yolks and can bounce like rubber after being boiled have appeared on the market in several regions across China, leading a food safety watchdog in Shanghai to launch a probe, officials said Friday.

Mylan Inc. today announced that a jury has rendered an unfavorable verdict in a patent infringement lawsuit filed by Sunovion Pharmaceuticals Inc., f/k/a Sepracor Inc., against Mylan Inc., Mylan Pharmaceuticals Inc., Dey Inc.

The Drug Enforcement Administration suspended Cardinal's license, alleging four of the center's retail pharmacy customers dispensed controlled substances that were issued for other than a legitimate medical purpose and outside the usual course of professional practices.

Post letters to Letters to the Editor, The Daily Times, 41-N, Industrial Area, Gulberg II, Lahore, Pakistan Phone: 92-42-5878614-19; Fax: 92-42-5878620 E-mail: letters@dailytimes.com.pk E-mail: letters.dt6@gmail.com Letters may be edited for length and clarity Child beggars Sir: Child beggary seems to be increasing at an alarming speed in our ... (more)

A unit of Bayer AG, Germany's largest drugmaker, sued Watson Pharmaceuticals Inc., accusing the generic-drug maker of violating a patent for Beyaz birth control pills.

Feb. 09--Mylan Inc. CEO Heather Bresch urged Washington lawmakers today to approve a new $300 million a year fee on the generic drug industry and to update a law that will give federal regulators greater power to inspect foreign pharmaceutical facilities.

My blogger friend Rich Meyer went on a bit of a rant against "bad journalism" and how pharma is often misrepresented in the news media .

London, Feb 10: Singer Elton John is urging officials to stop plans to restrict India's pharmaceutical industry, branding the proposals an "attack on the health of the world's poor". The 64-year-old, who is a long time supporter of Aids charities, is unhappy about the situation and he wants government bosses in Britain to intervene, reports ... (more)

HAYWARD, Calif.-- --Feb 9, 2012 - Impax Laboratories, Inc. today provided an update on the status of its resolution of the previously disclosed warning letter issued by the U.S. Food and Drug Administration covering its Hayward manufacturing facility.

Indian Minister for Commerce and Industry Anand Sharma, left, talks with European Union Commissioner Kari De Gucht during a meeting in New Delhi, India, Thursday, Feb.

Louisville-based PharMerica, which provides pharmaceutical services to long-term care facilities such as nursing homes and assisted-living centers, reported net income of $7.9 million, or 27 cents per share, up from $4.7 million, or 16 cents per share, a year earlier, according to a news release.

Just three months before the world's second-best-selling drug gets U.S. generic competition, a generics company has paid nearly $445 million to finally end a decade-long, twist-filled patent infringement battle with two heavyweight drugmakers over blood thinner Plavix.

S&P 500 component Watson Pharmaceuticals, Inc. will unveil its latest earnings on Tuesday, February 14, 2012.

Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.

The P.I.C. scandal confirms the urgent need for investigations into quality control at drug-testing facilities, licensing protocols for the pharmaceutical industry and the training of doctors at government-run hospitals.

Watson Pharmaceuticals Inc. Chief Executive Officer Paul Bisaro is looking to acquire brand-name drug assets and make a future "'transformational'' purchase as he reshapes the generic-drug maker.

As Rainbow BioSciences, the biotech division of Rainbow Coral Corp. , continues to vet investment banks to assist with its capital raise, investors remain optimistic on the returns that new biotech firms can bring.